Hi, Ive also requested a DWAC through IBKR, it's asking for...

First 66 Last

Share
Profile

Follow
Yjzl

2 Posts.

08/11/23

06:50

Post #: 70776237
Share

Originally posted by pJo9999: ↑

With respect to the IB fees. You should assume you'll be on the Fixed price - I'm not sure who gets on the tiered, but by the look of it people a lot richer than me. I don't _think_ anyone here is going to be trading over 300,000 CREV shares per month!

On the fixed tier you will pay US$0.005 per share with a minimum of $1. That's half a cent per share.

On 200 CREV that's US$1. With NAB that same trade would be around $30 or so (depending on CREV price, but assuming it comes to over $20k. IB is definitely cheaper. Further, exchanging the US$ to A$ is cheaper with IB than anywhere else I could find.

My actual experience was that the commission was slightly higher. On an expected US$2.60 commission I seemed to actually pay $3.22. I did not investigate why as it is a trivial amount either way.

My reading of the "1% max" is that that is the most you will pay. That would presumably be if you were selling shares under US 50c/share. Let's hope we're not ever in that position with CREV. But note if we sold 1000 shares at 50c/share, the max 1% would be $5. NAB would be $9.95.

If you sign up with IB, please use my referral link. I get money, you get some free shares in IB.

https://ibkr.com/referral/patrick4257 As for the DWAC, mine has not been rejected, but it has not been completed either. I have my fingers crossed for tomorrow.

Also note however, IB does have a fee of US$100 for a successful DWAC (failed DWACs are free). I have no idea what other brokers charge for this.

Expand

Hi, Ive also requested a DWAC through IBKR, it's asking for proof of purchase but there's no way to actually upload any documents for me. Will call them today to try work it out.

if you have had any luck please let me know!

CBR Price at posting: 13.5¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 106 more messages in this thread...

First 66 Last

Add CBR (ASX) to my watchlist

Hi, Ive also requested a DWAC through IBKR, it's asking for...

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News